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Abstract
Schwann cells within the peripheral nervous system possess a remarkable regenera-
tive potential. Current research shows that peripheral nerve-associated Schwann
cells possess the capacity to promote repair of multiple tissues including peripheral
nerve gap bridging, skin wound healing, digit tip repair as well as tooth regeneration.
One of the key features of the specialized repair Schwann cells is that they become
highly motile. They not only migrate into the area of damaged tissue and become a
key component of regenerating tissue but also secrete signaling molecules to attract
macrophages, support neuronal survival, promote axonal regrowth, activate local
mesenchymal stem cells, and interact with other cell types. Currently, the importance
of migratory Schwann cells in tissue regeneration is most evident in the case of a
peripheral nerve transection injury. Following nerve transection, Schwann cells from
both proximal and distal nerve stumps migrate into the nerve bridge and form
Schwann cell cords to guide axon regeneration. The formation of Schwann cell cords
in the nerve bridge is key to successful peripheral nerve repair following tran-
section injury. In this review, we first examine nerve bridge formation and the behav-
ior of Schwann cell migration in the nerve bridge, and then discuss how migrating
Schwann cells direct regenerating axons into the distal nerve. We also review the
current understanding of signals that could activate Schwann cell migration and sig-
nals that Schwann cells utilize to direct axon regeneration. Understanding the molec-
ular mechanism of Schwann cell migration could potentially offer new therapeutic
strategies for peripheral nerve repair.
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1 | INTRODUCTION
In contrast with the central nervous system (CNS), the peripheral
nervous system (PNS) has a remarkable ability to regenerate following
injury, and Schwann cell plasticity contributes significantly to this
capacity (Boerboom, Dion, Chariot, & Franzen, 2017; Carr &
Johnston, 2017; Jessen & Mirsky, 2005, 2016, 2019a). Schwann cells
in adult nerves are a regenerative cell type and they retain the ability
to revert to a repair competent state following nerve injury (Jessen &
Mirsky, 2019). Studies have shown that, among others, the transcrip-
tion factor cJun, as well as Merlin-dependent Hippo signaling play
major roles in reprogramming adult Schwann cells into a repair
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competent cell (Arthur-Farraj et al., 2012; Fontana et al., 2012;
Mindos et al., 2017; Schulz et al., 2016).
In response to injury, the area of nerve distal to the site of injury
undergoes a series of changes known as Wallerian degeneration, and
creates a permissive environment for subsequent axon regeneration
(Coleman & Freeman, 2010). Schwann cells in the distal nerve stump
break down their myelin and activate a program called myelinophagy for
myelin clearance (Brosius Lutz et al., 2017; Gomez-Sanchez et al., 2015;
Li et al., 2020). Schwann cells also play an active role in axon degradation
within the distal nerve, remodeling their actin cytoskeleton to produce
actin spheres that accelerate axon clearance (Vaquie et al., 2019). Within
6 hr of injury, Schwann cells in the distal nerve stump also produce and
secrete pro-inflammatory factors to recruit macrophages to further
accelerate clearance of axonal and myelin debris (Martini, Fischer, Lopez-
Vales, & David, 2008; Stratton et al., 2018; Zigmond &
Echevarria, 2019). Following their dedifferentiation, Schwann cells prolif-
erate and extend longitudinally to form bands of Büngner to help guide
axon regrowth; they also secrete cytokines, growth factors, neuro-
trophins and extracellular matrix molecules to promote neuronal survival
and axon regeneration (Jessen & Mirsky, 2016; Ma, Hung, &
Svaren, 2016). Stimulated by such retrograde injury signals, cytokines,
chemokines, growth factors, and neurotrophins, injured neurons rapidly
activate an intrinsic program and regenerate quickly toward their distal
targets (Abe & Cavalli, 2008; Navarro, Vivo, & Valero-Cabre, 2007;
Rishal & Fainzilber, 2010). Upon the contact with regenerating axons,
Schwann cells remyelinate regenerated axons and repel infiltrated mac-
rophages to complete the process of peripheral nerve repair (Fry, Ho, &
David, 2007; Jessen & Mirsky, 2016).
Current evidence shows that peripheral nerve-associated
Schwann cells promote the repair of multiple tissue types including
peripheral nerve gap bridging, skin wound healing, and regeneration of
both digit tips and teeth (Carr & Johnston, 2017; Johnston et al., 2016;
Jones et al., 2019; Parfejevs et al., 2018). The injury-induced changes
not only reprogram denervated Schwann cells into a repair-competent
state, but may also give them a highly motile phenotype. These
Schwann cells then not only migrate into the area of injury to become a
key component of regenerating tissue, but also secrete growth factors
to activate local mesenchymal stem cells to drive tissue regeneration
(Johnston et al., 2016; Jones et al., 2019). The importance of migratory
Schwann cells in tissue regeneration is perhaps most evident in the case
of a peripheral nerve transection injury (Cattin et al., 2015; Dun
et al., 2019; Parrinello et al., 2010). Following nerve transection,
Schwann cells at the tips of the severed nerve stumps (i.e., distal tip of
the proximal stump and proximal end of the distal stump) undergo a pro-
cess of dedifferentiation, followed by proliferation and migration into
the nerve gap where they form Schwann cell cords and bridge the trans-
ected nerve stumps. The formation of Schwann cell cords is key to suc-
cessful peripheral nerve regeneration (Cattin et al., 2015; Chen, Chen,
Parkinson, & Dun, 2019; Dun & Parkinson, 2020; Parrinello et al., 2010).
This review article will focus on the behavior of Schwann cell
migration from the transected nerve ends into the nerve bridge and
discuss how migrating Schwann cells direct regenerating axons
toward and into the distal nerve stump. We will also review the cur-
rent understanding of signals that are proposed to activate Schwann
cell migration and mechanisms that Schwann cells utilize to direct
axon regeneration. We have recently reviewed signaling by axon guid-
ance molecules and its potential role in regulating the trajectories of
Schwann cell migration in the nerve bridge (Dun & Parkinson, 2020);
therefore, these aspects will not be covered in this present review
article.
2 | FORMATION OF NEW NERVE TISSUE
FOLLOWING INJURY, THE NERVE BRIDGE
2.1 | The nature of variable lengths of nerve gap
following transection
The rodent sciatic nerve transection has been widely used a research
model to understand the molecular mechanisms of peripheral nerve
regeneration after injury (Savastano et al., 2014). However, researchers
in this field have experienced that, with no attempted re-suturing of the
nerve ends, the lengths of the nerve gaps are variable following tran-
section (Bozkurt et al., 2011; Cattin et al., 2015; Chen et al., 2019;
Dun & Parkinson, 2018a; Parrinello et al., 2010; Savastano et al., 2014).
Like the majority of the peripheral nerves in mammals, the rodent sci-
atic nerve is under tension and therefore a nerve gap will be generated
upon transection injury due to the retraction of the nerve ends (Chen
et al., 2019; Dun & Parkinson, 2018a). In our experience, we normally
create a nerve gap varying between 1 and 2.5 mm (Figure 1a–c) (Chen
et al., 2019; Dun et al., 2019; Dun & Parkinson, 2015, 2018a, 2018b)
and these gaps may first be bridged by a fibrin deposit (Schroder,
May, & Weis, 1993; Williams, Longo, Powell, Lundborg, & Varon, 1983).
Perineurial cells are the first cell type from both severed nerve ends
migrating into the nerve gap (Martini, Schachner, & Faissner, 1990;
Schroder et al., 1993; Weis, May, & Schroder, 1994). Subsequently,
nerve fibroblasts, endothelial cells, and Schwann cells migrate into the
nerve gap and form new tissue to connect both nerve stumps. This
newly formed tissue is now known as the “nerve bridge” (Cattin
et al., 2015; Dun et al., 2019; Dun & Parkinson, 2015, 2020; Parrinello
et al., 2010). The nerve bridge serves as a substrate for regenerating
axons crossing the nerve gap.
In some cases of rodent sciatic nerve transection using a scissors,
the sciatic nerve could be detached from the attaching muscle during
the surgical procedure of transection, which often results in a further
retraction of both nerve ends and generates a longer gap. Under such
circumstances, a fibrin deposit cannot form to connect both nerve
ends due to the leakage of the fibrin clot in the larger nerve gap
(Belkas, Shoichet, & Midha, 2004; Lundborg, Dahlin, et al., 1982;
Zhao, Dahlin, Kanje, & Lundborg, 1993); therefore, a nerve bridge
does not form and regeneration cannot occur in such a large nerve
gap without surgical repair. In our work using the proteolipid protein-
green fluorescent protein (PLP-GFP) mice which labels Schwann cells
with GFP (Mallon, Shick, Kidd, & Macklin, 2002), we observed that a
2 MIN ET AL.
gap distance of greater than 3.5 mm between the nerve stumps was a
barrier to correct nerve bridge formation (Figure 1d,e).
2.2 | Stages of nerve bridge formation
We, and others, typically use mouse and rat sciatic nerve transection
as a research model to create nerve gaps and study the molecular and
cellular events regulating axon regeneration across such peripheral
nerve gaps (Chen et al., 2019; Dun et al., 2019; Dun & Parkinson, 2015,
2018a; Parrinello et al., 2010; Savastano et al., 2014). Following a sciatic
nerve transection, numerous erythrocytes, granulocytes, thrombocytes,
and macrophages are localized into the nerve gap (Schroder et al., 1993;
Weis et al., 1994; Williams et al., 1983). These cells are the earliest cell
types arriving into the nerve bridge, and they are released from the
transected endoneurial and epineurial blood vessels of the nerve rather
than migration into the nerve gap from either nerve stump. In rat sciatic
nerve transection injury, the nerve gap is first bridged by a fibrin deposit
between the distal and the proximal nerve stumps at 2 days following
transection (Cattin et al., 2015). At Day 2 postinjury, the nerve bridge
is composed of approximately 50% macrophages, 24% neutrophils,
13% fibroblasts, 5% endothelial cells, and 8% other cell types (Cattin
et al., 2015). Perineurial cells respond rapidly to nerve transection and
they are the earliest cell type migrating into the nerve bridge from both
nerve ends (Kucenas, 2015; Lewis & Kucenas, 2014). Perineurial cells
migrate along the fibrin deposit and form a circumferential tube to con-
trol the trajectory of migration of both nerve fibroblasts and endothelial
cells (Martini et al., 1990; Schroder et al., 1993; Weis et al., 1994).
At Day 3 postinjury, the number of endothelial cells shows a signifi-
cant increase to 20% in the nerve bridge due to the dramatic influx of
endothelial cells from both nerve ends toward the middle of the bridge.
Neutrophils also show a slight increase to 26%, while the ratio of macro-
phages decreased to 33% and the ratio of fibroblasts decreased to 10%,
showing a dynamic and changing cell composition of the nerve bridge
(Cattin et al., 2015). Recently, an mRNA sequencing study revealed
that macrophages within the nerve bridge show a complex phenotype,
which is temporally regulated by the nerve bridge microenvironment
(Tomlinson, Zygelyte, Grenier, Edwards, & Cheetham, 2018). We also
showed that macrophages in the outermost layer of the nerve bridge
have both a different morphology and gene expression profile compared
to macrophages localized in the center of the nerve bridge (Dun
et al., 2019). Using single-cell transcriptomics, Ydens et al. demonstrated
that macrophages in the injured mouse sciatic nerve express a unique
transcriptional profile compared with macrophages in other mouse tis-
sues (Ydens et al., 2020). Endothelial cells from both nerve ends are
attracted by vascular endothelial growth factor-A (VEGF-A) secreted
from macrophages in the nerve gap, they migrate into the nerve gap
and form new blood vessels (Cattin et al., 2015).
The majority of newly formed blood vessels are orientated longitudi-
nally in the nerve bridge (Cattin et al., 2015; Schroder et al., 1993; Weis
et al., 1994) and they serve as a substrate for subsequent Schwann cell
migration (Cattin et al., 2015). Schwann cells from both proximal and
F IGURE 1 The length of the sciatic nerve gap affects
Schwann cell cord formation within the nerve bridge. Z-stack
images were captured using confocal microscopy with
reconstruction from whole sciatic nerve preparations 14 days after
transection injury in PLP-GFP mice (GFP+ Schwann cells). Dashed
lines indicate the cut ends of both proximal (left) and distal (right)
nerve stumps. (a) Schwann cell cords connecting the proximal and
the distal nerve stumps in a 1.17 mm sciatic nerve gap.
(b) Schwann cell cords connecting the proximal and the distal
nerve stumps in a 1.69 mm sciatic nerve gap, some Schwann cells
have left the nerve bridge in the proximal nerve stump.
(c) Schwann cell cords connecting the proximal and the distal
nerve stumps in a 2.49 mm sciatic nerve gap with more Schwann
cells observed leaving the nerve bridge in the proximal nerve
stump. (d) With a larger sciatic nerve gap (3.35 mm), only a few
Schwann cell cords connect the proximal and the distal nerve
stumps. (e) In a 4.11 mm sciatic nerve gap, migrating Schwann
cells are unable to form Schwann cell cords and do not connect
both nerve stumps to form a nerve bridge. GFP, green fluorescent
protein; PLP, proteolipid protein
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distal nerve stumps migrating toward the nerve bridge can be easily
observed passing both nerve stumps on Day 4 postinjury, and they form
Schwann cell cords within the nerve bridge by Day 7 (Chen et al., 2019;
Torigoe, Tanaka, Takahashi, Awaya, & Hashimoto, 1996). Slit3-Robo1
signaling between Slit3-expressing macrophages and Robo1-expressing
migrating Schwann cells in the nerve bridge is required to keep Schwann
cells inside the nerve bridge (Dun et al., 2019). EphrinB2-EphB signaling
between migrating nerve fibroblasts and Schwann cells is important for
Schwann cell sorting and Schwann cell cord formation in the nerve
bridge (Parrinello et al., 2010). For a further review of the molecular
mechanism of classic axonal guidance signaling pathways and their
potential roles in regulating the nerve bridge formation, please see our
recent review (Dun & Parkinson, 2020). Regenerating axons are known
to follow Schwann cell cords and navigate across the nerve bridge
(Cattin et al., 2015; Chen et al., 2019; Dun et al., 2019; Parrinello et al.,
2010). For a 2 mm nerve gap, axons begin to enter the distal nerve
stump around Day 9 following a transection injury (Chen et al., 2019).
Thus, macrophages, neutrophils, perineurial cells, nerve fibroblasts,
endothelial cells, and Schwann cells are the major cell types forming
the nerve bridge and they regulate each other's recruitment, migration,
and organization in the nerve bridge during regeneration (Cattin
et al., 2015; Dun et al., 2019; Kucenas, 2015; Parrinello et al., 2010;
Weis et al., 1994; Williams et al., 1983). The formation of the nerve
bridge requires an initial fibrin deposit and then involves the coordi-
nated migration of multiple cell types. The cellular make-up and extra-
cellular matrix composition of the nerve bridge changes over time
following injury, but as regeneration proceeds the nerve bridge will be
replaced largely by Schwann cells and axons, and in time will have a
somewhat similar tissue structure to the repaired distal nerve stump.
2.3 | The study of nerve bridge formation using
artificial nerve conduits
The clinical challenge in the repair of larger peripheral nerve gaps
requires the use of biodegradable nerve guidance conduits and several
have been developed to repair such nerve gaps of between 5 and
10 mm (Deumens et al., 2010; Kehoe, Zhang, & Boyd, 2012; Ray &
Mackinnon, 2010). Therefore, understanding the time course of nerve
bridge formation and axon regeneration in nerve guidance conduits
will improve the design and the use of nerve guidance conduits in
the clinic. In order to study nerve bridge formation in vivo and axon
regeneration over longer nerve gaps, Lundborg et al. developed an
injury research model by connecting the severed nerve ends using sili-
cone tubing (Lundborg, Dahlin, et al., 1982; Lundborg, Gelberman,
Longo, Powell, & Varon, 1982). They showed that the nerve bridge
could still form within such a hollow silicone tube for a rat sciatic
nerve gap up to 10 mm in length (Lundborg, Dahlin, et al., 1982). The
spatial–temporal progress of cellular events of nerve bridge formation
within the silicone tube have been studied in some detail with such a
10 mm rat sciatic nerve gap (Figure 2) (Williams et al., 1983).
Within 1 day of surgery, the silicone conduit tube was filled with
fluid originating from both nerve ends (Belkas et al., 2004; Lundborg,
Longo, & Varon, 1982). Using in vitro neuron cultures, the fluid within
the silicone tube was shown to contain neurotrophic factors and
extracellular matrix and to stimulate axon growth (Lundborg, Longo, &
Varon, 1982). Three days after surgery, a fibrin cord could be observed
inside the silicone tubes connecting both nerve ends and the fibrin
cord contained numerous erythrocytes, granulocytes, thrombocytes,
and macrophages (Schroder et al., 1993; Weis et al., 1994; Williams
et al., 1983). The fibrin cord had a parallel and longitudinal arrange-
ment to the nerve and provided a substrate for cells from both nerve
ends migrating into the nerve bridge (Williams et al., 1983). As for
formation of the bridge without a conduit, perineurial cells were the
first cell type from both nerve ends to migrate along the fibrin cord
and could be easily observed at Day 7 with an elongated cell
shape (Schroder et al., 1993; Weis et al., 1994). Migrating perineurial
cells formed a perineurial cell tube surrounding the fibrin and this
tube almost bridged the 10 mm gap at Day 12 following tran-
section and repair with the silicone conduit (Figure 2). A continuous
tube of perineurial cells connecting the proximal and distal nerve
stumps could still be observed at 18 days following surgery. Nerve
fibroblasts, endothelial cells, and Schwann cells from both nerve
stumps were found to migrate within the perineurial tube toward the
middle of the nerve bridge. They migrate at a distance of up to 1 mm
from both nerve stumps at Day 7 and almost reach the middle of the
nerve bridge at Day 12 (Figure 2). Migrating nerve fibroblasts, endo-
thelial cells, and Schwann cells filled the whole nerve gap within the
perineurial tube and formed a continuous cellular cord by Day 18 fol-
lowing surgical repair (Lundborg, Dahlin, et al., 1982; Scaravilli, 1984).
Regenerating axons enter the distal nerve stump on Day 21 following
surgical repair in this model (Weis et al., 1994).
3 | TRANSGENIC MOUSE MODELS
EXPRESSING FLUORESCENT PROTEINS IN
SCHWANN CELLS, USEFUL TOOLS TO STUDY
SCHWANN CELL MIGRATION IN VIVO
The use of transgenic mouse models expressing fluorescent proteins
in Schwann cells such as PLP-GFP (Mallon et al., 2002), S100-GFP
(Zuo et al., 2004), S100-RFP (Hirrlinger et al., 2005), and Sox10-Venus
(Hirrlinger et al., 2005) have allowed the detailed analysis of Schwann
cell behavior and migration following nerve injury. The S100-GFP
mouse model was the first mouse model to be used to study Schwann
cell migration in vivo after sciatic nerve transection (Hayashi et al.,
2007; Tomita et al., 2009; Whitlock et al., 2010). In S100-GFP mice,
Schwann cells are labeled with GFP under the control of transcrip-
tional regulatory sequences of the human S100B gene. Although
Schwann cells are labeled with bright GFP, studies have shown that a
few macrophages also express GFP in this transgenic mouse line (Zuo
et al., 2004). More recently, the PLP-GFP mice have been used to visu-
alize in vivo Schwann cell migration (Carr, Parkinson, & Dun, 2017;
Cattin et al., 2015; Dun et al., 2019; Stierli et al., 2018). Originally cre-
ated to label oligodendrocytes in the CNS, with GFP expression driven
by the mouse myelin PLP gene promoter, the PLP-GFP mice express
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cytoplasmic GFP in both myelinating and nonmyelinating Schwann
cells of the peripheral nerves (Mallon et al., 2002). Myelinating
Schwann cells and nonmyelinating Schwann cells in the intact nerve
are also distinguishable in adult PLP-GFP mice due to a much higher
apparent level of GFP expression in nonmyelinating Schwann cells and
the recognizable morphology of Remak bundles (Carr et al., 2017;
Stierli et al., 2018). Transgenic mice expressing Schwann cell specific
Cre-recombinase have also been used to label Schwann cells by cross-
ing with different fluorescence protein reporter lines such as R26R-
YFP, R26R-tdTomato, and R26R-Confetti (Benito et al., 2017; Clements
et al., 2017; Feltri et al., 1999; Leone et al., 2003; Livet et al., 2007;
Madisen et al., 2010; Srinivas et al., 2001; Stierli et al., 2018). These
mouse models allow researchers to study the basic behavior and the
molecular mechanism of Schwann cell migration in vivo within the
nerve bridge following mouse sciatic nerve transection injury.
4 | MIGRATING SCHWANN CELLS DIRECT
AXON REGENERATION IN THE NERVE
BRIDGE
Accumulating evidence indicates that regenerating axons are unable to
cross the nerve gap without Schwann cell guidance (Torigoe et al., 1996,
Parrinello et al., 2010, Webber et al., 2011, Rosenberg et al., 2014, Cattin
et al., 2015, Dun & Parkinson, 2015). In the zebra fish motor axon injury
model, generating just a 9 μm nerve gap by laser transection, reg-
enerating axons lost their directionality and travelled along ectopic trajec-
tories in the nerve bridge when Schwann cells were genetically ablated
(Rosenberg et al., 2014). In Sox2, Slit3, and Robo1 knockout mice,
Schwann cells migrated aberrantly after sciatic nerve transection injury
and regenerating axons followed the path of ectopic migrating Schwann
cells leaving the nerve bridge (Dun et al., 2019). More recently in the
PLP-GFP mice, we revealed that an early regrowing population of reg-
enerating axons is unable to cross the mouse sciatic nerve gap due to the
lack of Schwann cell guidance at their front (Chen et al., 2019). These
findings have shown that Schwann cells are the key cell type in the nerve
bridge to direct regenerating axons into the distal nerve stump.
4.1 | Misdirected axon regeneration without
Schwann cell guidance
It is well known that adult neurons of the peripheral nerves retain
the capacity to regenerate (Chen, Yu, & Strickland, 2007; Jessen &
F IGURE 2 Schematic of nerve bridge formation and axon
regeneration as seen in a 10 mm rat sciatic nerve gap repaired with a
hollow nerve conduit. (a) Rat sciatic nerve before injury. (b) At Day
3 following surgery and silicone tube repair, the gap between the
proximal and distal nerve stumps was bridged by a meshwork of fibrin
deposit. This fibrin meshwork contains many erythrocytes, neutrophils,
platelets, and macrophages. (c) At Day 7, the nerve bridge still contains
fibrin deposits, macrophages, and degenerating erythrocytes.
Perineurial cells from both nerve ends migrate along the fibrin deposit
and form circumferential tubes extending 2 mm from each nerve
stump at both ends of the nerve bridge. Inside the perineurial cell tube,
fibroblasts, endothelial cells, and Schwann cells from both nerve ends
have migrated approximately 1 mm into the nerve bridge. Newly
formed capillaries are mainly oriented longitudinally. Very few axons
could be observed in the proximal nerve stump and they are not
myelinated. (d) At Day 12, migrating perineurial cells have not yet met
in the middle of the nerve bridge with a gap distance about 0.5 mm
between proximal and distal migrating perineurial cells. There are
numerous fibroblasts, Schwann cells, and blood vessels inside the
perineurial cell tube. More axons have grown out of the proximal
stump and they are associated with Schwann cells but not yet
myelinated. Blood vessels start to grow ahead of fibroblasts and
Schwann cells. (e) At Day 18, a continuous perineurial cell tube is
formed surrounding the nerve bridge. Schwann cells, fibroblasts, and
blood vessels also meet in the middle of the nerve bridge. Axons reach
the midpoint of the nerve bridge, and are thinly remyelinated. (f) At
Day 21 postinjury, axons had reached the distal nerve stump and
Schwann cell remyelination is seen up to the midpoint of the bridge
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Mirsky, 2016) and they rapidly activate a remarkable intrinsic program
to regenerate in response to injury-induced retrograde signals (Rishal &
Fainzilber, 2010). Torigoe et al. used the film model and studied the initi-
ation of axon regeneration. In this film model, the transected mouse
proximal peroneal nerve was sandwiched between two thin plastic fluo-
rine resin films, resulting in a very thin layer of regenerating tissue being
formed between two films; therefore, tissue sectioning was not needed
for subsequent analysis in this model. Using this method, they analyzed
axon regeneration on the film in the early phase of regeneration up to
6 days. By transmission electron microscopy, they showed that neurite
sprouting could be observed at only 3 hr following axotomy from the
nodes of Ranvier adjacent to the axotomized nerve stump. Neurites
extended and passed through the proximal nerve stump tip and onto
the film in just 6 hr (Torigoe et al., 1996). The early time points of neu-
rite sprouting observed by Torigoe et al. were in agreement with
Sjöberg and Kanje's observation using an electrophysiological technique
(Sjoberg & Kanje, 1990). Using a live cell imaging system in the zebra
fish to study GFP-expressing motor axon regeneration, Isaacman-Beck
et al. also observed that regenerating axons have extended into the
nerve gap at just 7 hr following axotomy (Isaacman-Beck, Schneider,
Franzini-Armstrong, & Granato, 2015). Thus, axon regeneration could
be easily observed well within the first day after peripheral nerve
transection injury.
Following a sciatic nerve transection injury in rodents, Schwann
cells within the distal end of the proximal nerve stump and Schwann
cells within the proximal end of the distal nerve stump undergo a pro-
cess of dedifferentiation which takes 2–3 days to complete (Jessen &
Mirsky, 2016; Shin et al., 2017; Wang, Teng, & Huang, 2012). After
dedifferentiation they can proliferate and migrate, therefore, the start
of Schwann cell migration is 2–3 days later than the start of axon
extension in the proximal nerve stump (Figure 3) (Chen et al., 2019;
Torigoe et al., 1996). Using the film model, Torigoe et al. analyzed
Schwann cell migration on the film by S100 antibody staining. They
showed that there were no Schwann cells associated with reg-
enerating axons at Day 2 following injury and migrating Schwann cells
start to appear near the proximal nerve stump on Day 3. The number
of migrating Schwann cells in the proximal nerve stump gradually
increased on Day 4 and Schwann cells began to migrate in front of
F IGURE 3 Schematic showing Schwann
cell-axon interactions in the mouse sciatic
nerve bridge at different stages of
regeneration. Axons regenerate much earlier
than the start of Schwann cell migration
following mouse sciatic nerve
transection injury. Axons form bundles and
often have a ball shape at the regeneration
front when there are no Schwann cells
localizing ahead of the regenerating axons
front before Day 5. Schwann cells migrate in
front of axons from Day 5 onward and form
Schwann cell cords at Day 7. Leading Schwann
cells have two or three leading processes
before Day 7. Regenerating axons use
Schwann cell cords as a substrate and navigate
across the nerve bridge and most axons enter
into the distal nerve stump on Day 9
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regenerating axons front on Day 5 (Torigoe et al., 1996). However,
the nerve bridge was unable to form using the film model; therefore,
this research model cannot fully mimic the in vivo nerve bridge micro-
environment for Schwann cell migration and axon regeneration. Using
PLP-GFP mice, we have studied the detail of Schwann cell migration
and axon extension in the nerve bridge in the sciatic nerve (Chen
et al., 2019). We also found that regenerating axons regrow in front
of the GFP-positive migrating Schwann cells in the nerve bridge for
the first 5 days following mouse sciatic nerve transection injury (Chen
et al., 2019). Therefore, for the first 5 days following transection injury,
axons regenerate into the nerve bridge tissue without Schwann cell
guidance at their front (Figure 3).
Torigoe et al. showed that regenerating axons fasciculated with
each other and formed axon bundles where there were no migrating
Schwann cells at the regeneration front. They termed these reg-
enerating axons as “naked axons” at this stage of regeneration (Torigoe
et al., 1996). Using the whole nerve neurofilament antibody staining
technique, we also showed that groups of 5–6 regenerating axons
formed bundles in the proximal nerve stump on Day 4 and a ball shape
often forms at the tips of such axon bundles (Chen et al., 2019; Dun &
Parkinson, 2015). The ball shape has been clearly illustrated by Ramón y
Cajal with his drawing of regenerating axons in the nerve bridge
(Lobato, 2008). This is a typical shape for stalled growth cones due to
the lack of a substrate for elongation (Dun et al., 2012; Lobato, 2008). In
the PLP-GFP mice, we also observed that some single axons could
extend into the nerve bridge on Day 4 when there were no Schwann
cells at the front, but such regenerating axons appeared to lack direc-
tionality and were not growing toward the distal nerve stump (Chen
et al., 2019). The growth cone morphology and lack of directionality of
regenerating axons in the nerve bridge at this early stage of regenera-
tion indicate that regenerating axons require Schwann cells at their front
to permit the correct trajectory of axon growth.
4.2 | Migrating Schwann cell direct regenerating
axons across the nerve bridge
Although Schwann cell migration starts later than axon extension in the
proximal nerve stump, Schwann cells overtake regenerating axons on
Day 5 and thereafter provide a pathway for regenerating axons navi-
gating across the nerve bridge (Cattin et al., 2015; Dun et al., 2019;
Dun & Parkinson, 2015; Parrinello et al., 2010). Both Torigoe's and our
studies showed that migrating Schwann cells start to proceed in front
of regenerating axons in the proximal nerve stump from Day 5 onward
following injury (Chen et al., 2019; Torigoe et al., 1996). Following
the pioneer Schwann cells, other Schwann cells attach to each other
and form a chain to migrate toward the middle of the nerve bridge
from both nerve stumps (Chen et al., 2019). Schwann cell migration in
the nerve bridge appears as a classic example of cell chain migration
(Aigouy, Lepelletier, & Giangrande, 2008; Dun & Parkinson, 2015;
Parrinello et al., 2010). This chain migration is important for the correct
Schwann cell cord formation in the nerve bridge (Figure 3). Interest-
ingly, Schwann cells from both nerve ends form chains and migrate
toward the middle of the nerve bridge. However, it is currently not
known if the migration stops once Schwann cell chains from both nerve
ends meet in the middle of the nerve bridge or they continue to migrate
toward the opposite nerve ends.
On Day 6, when there are many migrating Schwann cells localiz-
ing ahead of the axon front, individual axons emerge from axon bun-
dles and follow migrating Schwann cells across the nerve bridge (Chen
et al., 2019). Thus, regenerating axons are directed into the distal
nerve stump by Schwann cell cords formed by migrating Schwann
cells. Similar to this regeneration process of adult Schwann cells deter-
mining the directionality of axon elongation, during embryonic PNS
development, about 80% of the nerve front surface is covered by
Schwann cell precursors. It is the Schwann cell precursors that are
most exposed to the extracellular environment and they form a sub-
strate for advancing growth cones (Wanner, Guerra, et al., 2006;
Wanner, Mahoney, et al., 2006).
Both the film model study and our observations in PLP-GFP mice
showed that the speed of axon extension has two phases, an initial
slow phase (86 μm/day) when there are unaccompanied axons at the
front, followed by a faster phase (433 μm/day) when Schwann cells
migrate together with axons. The appearance of migrating Schwann
cells into the regeneration front coincides with the onset of the sec-
ond phase of axon growth; therefore, migrating Schwann cells are
responsible for the acceleration of axonal growth in the second phase
(Torigoe et al., 1996). These observations showed that migrating
Schwann cells not only direct axons regenerating toward the distal
nerve stump but also increase the speed of axon extension.
5 | IDENTIFYING THE SUBSTRATE FOR
SCHWANN CELL MIGRATION IN THE NERVE
BRIDGE
5.1 | Fibrin deposit, a possible substrate for
Schwann cell migration
Since Williams et al. first showed that a fibrin cord can serve as a sub-
strate for cells from both nerve stumps migrating into the bridge
(Williams et al., 1983), fibrin has been considered as the likely substrate
for Schwann cell migration into the nerve bridge (Belkas et al., 2004;
Daly, Yao, Zeugolis, Windebank, & Pandit, 2012; Deumens et al., 2010).
Later Weis et al. showed that the diameter of the fibrin cord within the
10 mm silicone tube was reduced between Days 3 and 7, and in some
of the silicone tube samples, the fibrin cord had already mostly dis-
appeared by Day 7 (Schroder et al., 1993; Weis et al., 1994). However,
at Day 7, Schwann cells have only migrated approximately 1 mm away
from both nerve stumps within the 10 mm silicone tubes (Williams
et al., 1983), indicating that migrating Schwann cells must find a new
substrate for migration in order to bridge the rest of the 8 mm gap
between the advancing cell fronts. Furthermore, in vitro Schwann cell
migration assays on mixed fibrin/fibronectin substrates demonstrated
that increasing the amount of fibrin in the substrates inhibited Schwann
cell migration (Akassoglou, Akpinar, Murray, & Strickland, 2003).
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Although a positive effect for peripheral nerve gap repair has been seen
using fibrin matrices to deliver growth factors into nerve guidance con-
duits, these observed positive effects may have rather resulted from
the use of growth factors in the fibrin matrices (Wood, Moore,
et al., 2009; Wood, Borschel, & Sakiyama-Elbert, 2009). Therefore, it
remains to be examined in vivo to what extent Schwann cells migrate
along a fibrin substrate.
5.2 | Schwann cells migrate along the regenerating
axons in the proximal nerve stump at early stages of
regeneration
Using the film model, Torigoe et al. analyzed Schwann cell migration
on the film and showed that proximal Schwann cells preferred axonal
surfaces over any other environmental structure as a substrate for
migration (Torigoe et al., 1996). Combining our whole sciatic nerve
neurofilament staining technique with use of the PLP-GFP mice, we
also showed that Schwann cells use axons as a substrate to migrate
upon in the proximal nerve stump before Day 5 (Chen et al., 2019).
During PNS development, Schwann cell precursors migrate as a con-
tinuous chain along the developing nerves (Sepp & Auld, 2003; Sepp,
Schulte, & Auld, 2000), and N-cadherin expression in Schwann cell
precursors has been proposed as the primary reason that Schwann
cell precursors migrate along the developing nerves (Wanner, Guerra,
et al., 2006). Following injury, Schwann cells upregulate N-cadherin
expression (Parrinello et al., 2010; Roberts et al., 2017), and in vitro
coculture of adult rat Schwann cells with embryonic dorsal root gan-
glion neurons revealed that N-cadherin mediates Schwann cell align-
ment along axons (Wanner & Wood, 2002). Thus, the expression
of adhesion molecules such as N-cadherin on Schwann cells could be
one reason that Schwann cells in the proximal nerve stump initially
use regenerating axons as a substrate to migrate before Day 5
(Figure 4). However, Schwann cells have to find new substrate to
migrate upon from Day 5 onward once they proceed in front of reg-
enerating axons. Furthermore, there are no axons acting as substrates
for Schwann cell migration from the distal nerve stump, indicating that
Schwann cells require a different type of substrate upon which to
migrate into the nerve bridge.
5.3 | Newly formed blood vessels as a substrate
for guiding Schwann cell migration and cord formation
Schroder et al. observed that Schwann cells concentrated around the
outgrowing blood vessels in the silicone tubes (Schroder et al., 1993),
F IGURE 4 Signals activating Schwann cell migration and substrates for Schwann cell migration in the nerve bridge. Upon nerve transection,
macrophages in the nerve bridge sense hypoxia and upregulate vascular endothelial growth factor (VEGF) to induce blood vessel regeneration.
The Schwann cell intrinsic migration property is activated by a number of growth factors illustrated. Upon putative activation of mitogen-
activated protein kinase (MAPK), Cdc42, Rac1, and RhoA signaling, Schwann cells at both nerve ends actively search for a substrate and migrate.
In the proximal nerve stump, Schwann cells initially use regenerating axons as a substrate to migrate, but then use blood vessels as an alternative
substrate once they overtake elongating axons. Schwann cells in the distal nerve stump also use blood vessels as substrate to migrate. Migrating
Schwann cells from both nerve ends meet in the middle of the nerve bridge and form Schwann cells cords to direct axon regeneration. Nerve
growth factor (NGF), BDNF, and glial cell line derived neurotrophic factor (GDNF) are critical signals that Schwann cells utilize to direct axons into
the distal nerve stump
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which was later investigated by Cattin et al. to show that Schwann
cells use newly regenerated blood vessels in the nerve bridge as a
substrate for migration (Cattin et al., 2015). In their studies, Cattin
et al. first showed that blood vessels emanate from both proximal
and distal stumps after sciatic nerve transection injury in mouse and
rat, and the nerve bridge is fully vascularized prior to the start of
Schwann cell migration. Around 80% of newly regenerated blood
vessels in the nerve bridge were orientated in the same direction as
subsequent Schwann cell migration. Immunostaining of the vascula-
ture in the nerve bridge of PLP-GFP mice showed that migrating
Schwann cells closely associated with the blood vessels in the bridge.
Schwann cells frequently make direct physical contacts with blood
vessels via long protrusions (Cattin et al., 2015). Moreover, it was
demonstrated in vitro that Schwann cells are able to migrate along
capillary-like endothelial cells using an in vitro system (Cattin
et al., 2015).
Cattin et al. further showed that most macrophages (>80%)
sense the hypoxic environment in the nerve bridge and increase
Hypoxia-Inducible Factor 1-alpha (HIF-1a) expression. Subsequently,
HIF-1a drives VEGF-A expression in macrophages (Figure 4). Using
a Transwell assay, they demonstrated that endothelial cells migrate
in response to VEGF-A but not Schwann cells. To address whether
VEGF-A induced blood vessel formation was sufficient to direct
Schwann cell migration in vivo, Cattin et al. implanted heparin beads
loaded with recombinant human VEGF165 into the nerve gap in vivo
to attempt to misdirect blood vessel regeneration. Six days after
VEGF-A bead implantation, they found that Schwann cells followed
the misdirected regenerating blood vessels and migrated away from
the nerve bridge. Thus, Cattin et al. confirmed that the regenerating
blood vessels are the most important substrate in the nerve bridge for
Schwann cell migration (Cattin et al., 2015).
6 | THE INTRINSIC MIGRATORY
PROPERTY OF SCHWANN CELLS
Current research evidence suggests that the intrinsic migratory
properties of Schwann cells are activated during the processes of
dedifferentiation, and they then actively search for a substrate
and begin to migrate. The intrinsic migratory properties of Schwann
cells have been studied by Wang et al. using a single-cell migration
assay with cultured rat sciatic nerve explants (Wang et al., 2012),
which effectively mimics the in vivo Schwann cell response to injury
(Shin et al., 2017). Wang et al. showed that Schwann cells could
spontaneously migrate away from nerve explants onto laminin-
coated coverslips after 48–72 hr of culture. Migrating Schwann cells
from sciatic nerve explants display high motility with a majority of
them showing a bipolar morphology. Gatto et al. showed that asym-
metric ERM (ezrin, radixin, moesin) protein activation in retracting cell
processes was required to maintain a bipolar shape in Schwann cells
during migration (Gatto, Walker, & Lambert, 2003, 2007). To migrate
out from explants onto laminin-coated coverslips, dedifferentiated
Schwann cells first sent out long processes and then the nucleus
moved forward within the processes to the front end of the cell. The
back part of the cell processes then retracted and the front processes
extended once more (Wang et al., 2012). We recently showed in the
PLP-GFP mice that leading migratory Schwann cells in the nerve
bridge have two or three leading processes, suggesting that they are
responsible for detecting migrating substrate and/or guidance cues
(Chen et al., 2019).
7 | THE ACTIVATION OF SMALL GTPASES
AND MITOGEN-ACTIVATED PROTEIN
KINASE SIGNALING PATHWAYS FOR
SCHWANN CELL MIGRATION
7.1 | The activation of small GTPases for Schwann
cell migration
Signaling pathway analysis of RNA sequencing data from rat distal
sciatic nerve revealed that the activation of growth factor receptors,
G-protein coupled receptors and integrins following injury could pos-
sibly activate the Rho family of small GTPases Cdc42, Rac1, and RhoA
in Schwann cells (Wang, Shan, Pan, & Yi, 2018). The active forms of
Cdc42, Rac1, and RhoA are all key regulators of cytoskeletal dynamics
and Schwann cell migration (Feltri, Suter, & Relvas, 2008; Lambrechts,
Van Troys, & Ampe, 2004; Yamaguchi & Condeelis, 2007). Activated
Cdc42 and Rac1 regulate Schwann cell leading process extension and
soma translocation through the control of F-actin polymerization at
the front edge of leading process (Wang et al., 2012). Treatment of
cultured Schwann cells with cytochalasin D, an F-actin polymerization
inhibitor, resulted in the collapse and retraction of leading processes
and an inhibition of Schwann cell migration (Wang et al., 2012; Wang,
Teng, & Huang, 2013). Injection of cytochalasin D to the injury site
also inhibited Schwann cell migration in vivo (Wang et al., 2018).
Application of the RhoA inhibitor Y-27632 at the leading front of
migrating Schwann cells reduced soma translocation, indicating that
activated RhoA is required to regulate soma translocation during
Schwann cell migration (Wang et al., 2012, 2013; Wang et al., 2018).
Myosin II has also been identified as a key player in soma transloca-
tion in many types of cells and myosin II is known to be activated by
RhoA (Conti & Adelstein, 2008; Solecki et al., 2009). Schwann cells
lacking myosin II activity exhibit a multipolar morphology and fail to
elongate properly along the axon and myelinate during peripheral
nerve development (Wang, Tewari, Einheber, Salzer, & Melendez-
Vasquez, 2008). Myosin II activity displays a polarized distribution in
Schwann cells with the leading processes having higher levels of
active myosin II than the soma and trailing processes. Activation of
myosin at the front of the Schwann cell leading process accelerated
soma translocation. In contrast, inhibiting polarized myosin II activity
in the front of leading process not only induced the retraction of lead-
ing process but also inhibited soma translocation. Thus, RhoA activa-
tion is required to control polarized distribution of myosin II activity
in migrating Schwann cells and regulates soma translocation during
migration.
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7.2 | The activation of mitogen-activated protein
kinase signaling pathways for Schwann cell migration
Recent studies have found that Schwann cell migration could be
guided by endogenous electric fields (EFs) (McKasson, Huang, &
Robinson, 2008; Yao, Li, Knapp, & Smith, 2015). EFs have not only
been detected in developing and regenerating tissues (Hotary &
Robinson, 1990; McCaig, Rajnicek, Song, & Zhao, 2005) but have also
been used in human clinical trials to enhance the repair of spinal cord
injuries (Shapiro et al., 2005; Tator, 2005). McKasson et al. showed
that Schwann cells are more sensitive to EF-stimulated migration
than any other studied cell type. At 100 mV/mm-1, Schwann cells
showed a strong movement toward the anode rather than cathode
as hippocampal neurons and neural crest cells do (McKasson
et al., 2008). Reversal of EF poles reversed the direction of Schwann
cell migration (Yao et al., 2015). Further studies showed that EF stimu-
lation promoted the release of NGF and BDNF by Schwann cells,
and promoted neurite outgrowth (Huang, Ye, Hu, Lu, & Luo, 2010;
Koppes et al., 2014; Koppes, Seggio, & Thompson, 2011). Yao et al.
studied the differential gene expression between EF stimulated and
unstimulated rat Schwann cells using an RNA-seq approach. Pathway
analysis revealed that 10 pathways are upregulated while 21 pathways
are downregulated. Among these pathways, mitogen-activated protein
kinase (MAPK) pathway is the most significantly upregulated pathway
upon EF stimulation, indicating that MAPK pathway is important
for the regulation of Schwann cell motility. Indeed, all three canonical
MAPK pathways, ERK, p38, and JNK, are rapidly and consistently acti-
vated in Schwann cells after peripheral nerve injury (Agthong,
Kaewsema, Tanomsridejchai, & Chentanez, 2006; Parkinson et al.,
2008; Roberts et al., 2016; Sheu, Kulhanek, & Eckenstein, 2000;
Yamazaki et al., 2009; Yang et al., 2012). Knockout of cJun, a down-
stream target of JNK, prevented Schwann cell morphology change to a
migratory bipolar shape and reduced Schwann cell motility (Arthur-
Farraj et al., 2012), while overexpressing cJun in Schwann cells
increased cell motility (Huang et al., 2015). In vivo, overexpressing cJun
in Schwann cells also accelerated axonal regeneration, remyelination
and functional recovery after mouse sciatic nerve crush injury (Fazal
et al., 2017). The regulation and the activation of ERK, p38, and JNK
signaling pathways in Schwann cells requires the activation of mem-
brane receptors such as GPCRs, receptor tyrosine kinases, cytokines
receptors, and integrins. Thus, the further study of signaling molecules
that could interact with these receptors, in particular signaling mole-
cules that are upregulated in the peripheral nerves following injury, will
enable us to understand better the molecular mechanism driving
Schwann cell migration.
8 | SIGNALS PROMOTING SCHWANN CELL
MIGRATION TOWARD THE MIDDLE OF THE
NERVE BRIDGE
To date, the molecular mechanisms regulating Schwann cell migration
into the nerve bridge from both nerve ends are still poorly
understood. Current understanding about signals that have the ability
to promote Schwann cell migration are largely obtained from in vitro
studies and reports from studying PNS development (Cornejo
et al., 2010; Heermann & Schwab, 2013). During PNS development,
Schwann cell precursors derive from the neural crest, migrate along
axons, and mature to Schwann cells (Table 1). Using in vitro assays
such as wound healing assay and Transwell migration assays on cul-
tured Schwann cells, several signaling molecules including NRG1 Type
III, neurotrophins, erythropoietin and glial cell line derived neuro-
trophic factor (GDNF), have all been identified to promote the motility
and migration of Schwann cells along axons (Cornejo et al., 2010;
Heermann & Schwab, 2013). Although Schwann cells in the distal
nerve stump away from the transection site do not migrate, they are
activated and extend their length to serve as a substrate for axon
extension (Gomez-Sanchez et al., 2017). In this section, we will review
signals that are activated in the distal nerve stump during peripheral
nerve regeneration because these signals have the ability to promote
in vitro Schwann cell migration and some of them have been demon-
strated to promote in vivo Schwann cell migration (Figure 4, Table 1).
8.1 | Roles of neurotrophins, GDNF, and
insulin-like growth factor-1
Neurotrophins consist of NGF, BDNF, and neurotrophins 3-5 (NT3-5),
and they activate two structurally unrelated receptor types, the
Tropomyosin-receptor-kinase (Trk) and the p75 neurotrophin receptor
(p75NTR). During development, NT3 acts through the TrkC receptor
tyrosine kinase on Schwann cells and stimulates Schwann cell migra-
tion via Rac1/Cdc42 and c-Jun N-terminal kinase signaling pathways
(Yamauchi, Chan, & Shooter, 2003, 2004; Yamauchi, Miyamoto,
Tanoue, Shooter, & Chan, 2005). NT3 is downregulated upon the
onset of myelination and this downregulation is required for the
Schwann cell transition into the myelinating phenotype (Yamauchi
et al., 2003, 2004; Yamauchi et al., 2005). The expression of NT3 in
the adult peripheral nerves is very low and it is further downregulated
in the distal nerve stump following injury (Funakoshi et al., 1993; San-
tos, Gonzalez-Perez, Navarro, & Del Valle, 2016). Thus, NT3 is unlikely
to play a role in Schwann cell migration during peripheral nerve
regeneration.
In contrast, BDNF, NGF, GDNF, and insulin-like growth factor-1
(IGF-1) are all upregulated in injured peripheral nerves (Cheng,
Steinway, Delaney, et al., 2000; Funakoshi et al., 1993; Heumann
et al., 1987; Meyer, Matsuoka, Wetmore, Olson, & Thoenen, 1992; Pu,
Zhuang, & Ishii, 1995; Xu et al., 2013). BDNF was found to interact
with p75NTR and to inhibit NT3 induced Schwann cell migration during
development; BDNF-p75NTR interaction appears to be required to
enhance Schwann cell myelination rather than migration (Ng, Chen,
Mandemakers, Cosgaya, & Chan, 2007; Yamauchi et al., 2003, 2004;
Yamauchi et al., 2005). in vitro migration assays also showed that
BDNF has no effect on Schwann cell migration (Maniwa et al., 2003).
In contrast, NGF, GDNF, and IGF-1 are all able to promote migration
of cultured Schwann cells (Anton et al., 1994; Cao et al., 2007;
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Cheng, Steinway, Russell, & Feldman, 2000; Cornejo et al., 2010;
Ju et al., 2015; Maniwa et al., 2003), but it remains unclear if they play
an in vivo role in activating Schwann cell migration into the nerve
bridge following peripheral nerve transection injury.
8.2 | NRG1 Type I signaling
Expression of the soluble isoform of NRG1 Type I is significantly
increased in Schwann cells of the distal nerve following sciatic nerve
transection. NRG1 Type I mRNA in Schwann cells is undetectable in
uninjured nerves, but is strongly induced within 24 hr of injury and
remains upregulated until at least 2 weeks following injury (Carroll
et al., 1997; Stassart et al., 2013). An increase of NRG1 Type I protein
in Schwann cells was detected at 1 day following injury and persisted
for at least 4 weeks (Stassart et al., 2013). Mahanthappa et al. showed
that secreted NRG1 Type I could increase the motility of denervated
Schwann cells (Mahanthappa et al., 1996). Although NRG1 receptors
ErbB2 and ErbB3 are expressed in Schwann cells of uninjured nerves,
they are upregulated in response to injury, indicating an important
role of this signaling pathway in aspects of peripheral nerve regenera-
tion. The upregulation of ErbB2 and ErbB3 showed a similar pattern
as the NRG1 Type I upregulation. Sustained ErbB2 and ErbB3
upregulation is seen from 3 days postinjury (Carroll et al., 1997).
Guertin et al. showed that ErbB2 and ERK1/2 were strongly activated
at 4 days after injury in the distal nerve stump (Guertin, Zhang, Mak,
TABLE 1 Summary of signals regulating Schwann cell migration
Signals Receptors Signaling pathways In vivo upregulation in model system Migration assay methods
NGF p75NTR NFκB (Carter
et al., 1996).
Rat sciatic nerve transection (Funakoshi
et al., 1993; Heumann, Korsching,
Bandtlow, & Thoenen, 1987).
DRG explant culture onto sciatic nerve
sections (Anton, Weskamp, Reichardt,
& Matthew, 1994), chemotaxis
chamber (Maniwa, Iwata, Hirata, &
Ochi, 2003), sciatic nerve explant
migration assay, inverted coverslip
migration assay (Cao et al., 2007),
wound healing assay (Cornejo
et al., 2010).
GDNF Ret and GFRα1 ERK, CREB, PKA,
PKC
Mouse sciatic nerve crush (Naveilhan,
ElShamy, & Ernfors, 1997); Rat sciatic
nerve transection (Xu et al., 2013).
Wound healing assay (Cornejo
et al., 2010), Transwell migration
assay (Cornejo et al., 2010; Yi
et al., 2016).
IGF1 IGF1R PI-3 kinase, Rac1,
FAK
Rat sciatic nerve transection (Cheng
et al., 1996).
Gold motility assays (Cheng, Steinway,
Delaney, Franke, & Feldman, 2000;
Cheng, Steinway, Russell, &
Feldman, 2000).
Nrg1 Type I ErbB2 and
ErbB3
ERK, PI-3 kinase,
Rac1, CDC42,
JNK, cjun, Gab2,
Shp2, Src, FAK
Rat sciatic nerve transection (Carroll,
Miller, Frohnert, Kim, & Corbett, 1997),
Mouse sciatic nerve crush (Stassart
et al., 2013).
DRG explant culture onto sciatic nerve
sections (Mahanthappa, Anton, &
Matthew, 1996), wound healing assay
(Meintanis, Thomaidou, Jessen,
Mirsky, & Matsas, 2001), time-lapse
imaging (Foxd3:GFP Zebrafish) (Perlin,
Lush, Stephens, Piotrowski, &
Talbot, 2011).
HGF c-met ERK, CREB, c-fos,
AKT, Gab2
Mouse sciatic nerve crush (Ko, Lee, Lee,
Nho, & Kim, 2018).
Sciatic nerve explant migration assay
(Shin et al., 2017), Transwell migration
assay (Ko, Lee, Lee, et al., 2018; Ko,
Lee, Nho, & Kim, 2018), in vivo nerve
gap migration assay (Shin et al., 2017).
EPO EpoR ERK, Jak2 Rat sciatic nerve crush (Li, Gonias, &
Campana, 2005).
Transwell migration assay (Inoue
et al., 2010).
TNC β1-integrin Rac1 Rat sciatic nerve transection (Zhang
et al., 2016).
Transwell migration assay, wound
healing assay, in vivo nerve gap
migration assay (Zhang et al., 2016).
TGFβ1 TGFβR Smad2/3, ERK, JNK Rat sciatic nerve transection (Rufer,
Flanders, & Unsicker, 1994; Scherer,
Kamholz, & Jakowlew, 1993).
In vivo nerve gap migration assay
(Clements et al., 2017), wound healing
assay (Muscella, Vetrugno, Cossa, &
Marsigliante, 2020).
Abbreviations: EPO, erythropoietin; HGF, hepatocyte growth factor; IGF1, insulin-like growth factor 1; GDNF, glial cell line derived neurotrophic factor;
NGF, nerve growth factor; Nrg1, neuregulin1; TGFβ1, transforming growth factor β1; TNC, tenascin-C.
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Alberta, & Kim, 2005), but the activation of ErbB2 and ERK1/2 phos-
phorylation were absent in Schwann cell specific NRG1 Type I knock-
out mice, suggesting that the activation of ErbB2 and ERK1/2
is NRG1 Type I dependent (Stassart et al., 2013). Later studies have
revealed that several signaling pathways including MAPK, Rac1/
Cdc42-JNK, and Shp2-Src-FAK signaling pathways are also involved
in NRG1 Type I-induced Schwann cell migration (Grossmann et al.,
2009; Mahanthappa et al., 1996; Yamauchi, Miyamoto, Chan, &
Tanoue, 2008). These findings indicate that NRG1 Type I could be
one of the signals activating the intrinsic migratory properties of
Schwann cells.
8.3 | Hepatocyte growth factor signaling
Hepatocyte growth factor (HGF) is a paracrine cellular growth factor
and binds to the c-Met receptor. It has a major role in embryonic
organ development, cell migration, adult organ regeneration, and wound
healing (Imamura & Matsumoto, 2017; Nakamura, Sakai, Nakamura, &
Matsumoto, 2011). HGF protein levels are highly increased in fibroblasts
of the injured peripheral nerves (Ko, Lee, Lee, et al., 2018; Lee
et al., 2017), while the c-Met receptor is upregulated in dedifferentiated
Schwann cells (Ko, Lee, Lee, et al., 2018; Shin et al., 2017). Shin et al.
found that HGF cooperates with NRG1 and controls Schwann cell
migration through the regulation of Grb2-associated binder-2 (Gab2)
(Shin et al., 2017). NRG1 treatment upregulates Gab2 expression in cul-
tured Schwann cells and nerve explants through a Rac-JNK-cJun path-
way, but the tyrosine phosphorylation of Gab2 is not regulated by
NRG1-ErbB2 signaling (Shin et al., 2014; Shin et al., 2017). Screening
with receptor specific inhibitors in sciatic nerve explants to identify sig-
nals regulating Gab2 phosphorylation, Shin et al. found that crizotinib, a
selective c-Met inhibitor, suppressed the tyrosine phosphorylation of
Gab2, indicating that HGF regulates Gab2 phosphorylation in Schwann
cells (Shin et al., 2017). HGF treatment not only induced tyrosine phos-
phorylation of Gab2 but also induced c-Met phosphorylation, ERK and
AKT activation in Schwann cells (Ko, Lee, Lee, et al., 2018; Ko, Lee,
Nho, & Kim, 2018; Shin et al., 2017). HGF treatment also increased the
level of cJun expression in Schwann cells and promoted Schwann cell
migration (Ko, Lee, Lee, et al., 2018; Ko, Lee, Nho, & Kim, 2018; Shin
et al., 2017). Exogenous application of HGF around the injury site
enhanced peripheral nerve regeneration while treatment with a c-Met
inhibitor (PHA-665752) following injury inhibited peripheral nerve
regeneration (Ko, Lee, Lee, et al., 2018). Because both HGF and NRG1
regulate Schwann cell migration and Gab2 activity, the effect of Gab2
upon Schwann cell migration was investigated using Gab2 null mice. In
Gab2 null mice after sciatic nerve transection injury, the total number of
Schwann cells migrating into the nerve bridge was significantly reduced
and the number of regenerating axons entering the distal stump was also
significantly reduced (Shin et al., 2017). Schwann cells from Gab2 null
mice in culture exhibited shorter bipolar processes and a lack of basal
membrane ruffles upon HGF treatment. Thus, their studies confirmed
that HGF cooperates with NRG1 Type I and regulates Schwann cell
migration into the nerve bridge after peripheral nerve transection injury.
8.4 | Erythropoietin signaling
Inoue et al. showed that erythropoietin (Epo) is also significantly
increased in Schwann cells of the distal nerve following injury
(Li et al., 2005). The Epo receptor (EpoR) is expressed by Schwann cells
in intact peripheral nerves and its expression increased threefold at
7 days postinjury (Li et al., 2005). Epo treatment of injured nerves or
cultured Schwann cells induces EpoR tyrosine-phosphorylation, ERK
activation, and fibronectin expression. Epo treatment also recruits β1
integrin to the cell surface and promoted Schwann cell migration
(Inoue et al., 2010). JAK2, a nonreceptor tyrosine kinase, is also acti-
vated in Schwann cells following Epo binding to EpoR. When Schwann
cells were pretreated with a JAK2 inhibitor (AG490), Epo-induced β1
integrin relocalization to the cell surface was blocked, suggesting that
Epo stimulates Schwann cell migration by a JAK2-dependent mecha-
nism that promotes β1 integrin subunit relocation to the cell surface
(Inoue et al., 2010).
8.5 | Tenascin-C and betacellulin signaling
Recent advances in gene expression profiling have enabled
researchers to identify other novel signals that are highly upregulated
in the distal nerve stump with the ability to promote Schwann
cell migration. Tenascins are a highly conserved family of large oligo-
meric glycoproteins in the ECM of vertebrate organisms (Chiquet-
Ehrismann, Kalla, Pearson, Beck, & Chiquet, 1988). Tenascin-C (TNC),
one of the four members of the tenascin family, is dramatically
upregulated within injured peripheral nerves (Zhang et al., 2016).
Gene expression profile and pathway analysis with microarray data
from rat distal nerve stump predicted that TNC could regulate
cell migration though a β1-integrin-dependent pathway during
peripheral nerve regeneration. A subsequent study showed that TNC
is highly expressed in fibroblasts within injured peripheral nerves. Co-
immunoprecipitation assays demonstrated that TNC could directly
bind to β1-integrin on Schwann cells. TNC treatment of rat primary
Schwann cells increased Rac1 and RhoA activity and promoted
Schwann cell migration. In fibroblast and Schwann cell cocultures,
inhibition of TNC expression in fibroblasts suppressed Schwann cell
migration. Further studies using Matrigel to deliver exogenous TNC
protein in a 5 mm rat sciatic nerve gap showed that exogenous TNC
enhanced Schwann cell migration and axonal regrowth in vivo (Zhang
et al., 2016). Gene expression profiling also identified another highly
upregulated growth factor betacellulin (Btc) in Schwann cells of the
distal nerve stump (Vallieres et al., 2017). Btc is a ligand of the ErbB
family receptors and Schwann cells in the distal nerve stump are
known to express ErbB2 and ErbB3 (Carroll et al., 1997). Schwann
cells proliferate more actively in the distal sciatic nerve stump of Btc
overexpressing mice while they proliferate less in Btc knockout mice.
Btc overexpression was found to accelerate the recovery of sciatic
nerve function following injury (Vallieres et al., 2017). In endothelial
cells, Btc interacts with ErbB receptors and activates ERK and AKT
signaling to promote endothelial cell migration (Kim et al., 2003).
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However, the direct effect of Btc upon Schwann cell migration has
not yet been measured.
8.6 | Schwann cell partial epithelial-mesenchymal
transition and TGF-β1 signaling
Recently, Arthur-Farraj et al. showed that Schwann cells in the distal
nerve stump undergo a partial epithelial-mesenchymal transition (EMT)
following injury (Arthur-Farraj et al., 2017). EMT represents a process
of cellular reprogramming to convert epithelial cells to a motile mesen-
chymal phenotype (Kim et al., 2018). RNA-seq analysis has revealed the
enrichment of mRNAs and miRNAs for an EMT phenotype in mouse
distal nerve samples. This involved a downregulation of RNAs associ-
ated with EMT including E-cadherin, Wt1, Fgf1, Ndrg1, mir30, mir33,
and mir137, and upregulation of EMT associated RNAs including Tgfβ1,
Met, Hmga2, mir21, mir221, and mir222 (Arthur-Farraj et al., 2017).
EMT has been intensively studied in development and cancer, and is
now known to be controlled by multiple signals including secreted sig-
nals such as the TGFβ1 family proteins. Following peripheral nerve
injury, TGF-β1 is upregulated in Schwann cells, endoneurial fibroblasts,
and infiltrating macrophages (Kiefer, Streit, Toyka, Kreutzberg, &
Hartung, 1995; Parkinson et al., 2001; Rufer et al., 1994; Scherer
et al., 1993; Sulaiman & Nguyen, 2016). in vitro TGFβ1 treatment on
RSC96 Schwann cells promoted Schwann cell migration (Muscella
et al., 2020) and TGF-β1-treated Schwann cells are more effective in
promoting in vivo axonal regeneration (Sulaiman & Nguyen, 2016).
Clements et al. found that EMT signatures are more prominent in
Schwann cells in the bridge than Schwann cells in the distal nerve
stump, because the wound microenvironment in the nerve bridge
increases Schwann cell EMT characteristics (Clements et al., 2017).
Clements et al. also demonstrated that TGFβ1 signaling, localized in the
wound microenvironment, increased the Schwann cell EMT phenotype.
They studied Schwann cell migration in Schwann cell specific TGF-β
receptor II knockout mice and found that Schwann cell migration was
reduced in these mice (Clements et al., 2017). Therefore, it appears that
TGFβ1 is also a key mediator of Schwann cell migration within the
nerve bridge.
9 | SIGNALS THAT SCHWANN CELLS
UTILISE TO DIRECT AXONS ACROSS THE
NERVE BRIDGE
Dedifferentiated Schwann cells upregulate growth factors and neuro-
trophins such as NGF, BDNF, GDNF, VEGF, neurotrophin 4, glial
growth factor, ciliary neurotrophic factor, fibroblast growth factors
(FGFs), platelet-derived growth factor (PDGF), and IGFs (Gordon, 2009;
Jessen & Mirsky, 2016; Madduri & Gander, 2012). Using a variety of
approaches including Schwann cell or stem cell overexpression, viral
infection, nanoparticles, hydrogel, or Matrigel, these growth factors and
neurotrophins have been delivered into injured peripheral nerves and
their effects upon promoting axon regeneration have been extensively
examined (Hoyng et al., 2014; Madduri & Gander, 2012). Among all
the investigated growth factors and neurotrophins, NGF, BDNF, and
GDNF overexpression caused the trapping of regenerating axons and
the formation of axon coils (Eggers et al., 2013; Hoyng et al., 2014;
Santosa et al., 2013; Tannemaat et al., 2008). NGF overexpression selec-
tively trapped sensory axons and impaired sensory functional recovery
while BDNF overexpression selectively trapped motor axons and
impaired motor functional recovery. GDNF overexpression predomi-
nantly trapped motor axons and impaired motor functional recovery
(Hoyng et al., 2014). The outcome of axon entrapment has been consid-
ered as the result of NGF, BDNF, and GDNF's chemoattractant proper-
ties for axons (Dudanova, Gatto, & Klein, 2010; Tannemaat et al., 2008).
Certainly, any therapeutic use of these neurotrophins will require a
graded or strictly controlled time course of use, but these observations
indicated that migrating Schwann cells might utilize NGF, BDNF, and
GDNF as cues to direct axon regeneration in the nerve bridge (Figure 4).
NGF is specifically upregulated in Schwann cells from sensory
nerves, whereas the expression of BDNF is more pronounced in
Schwann cells from motor nerves (Hoke et al., 2006). NGF exclusively
promoted sensory axon regeneration while BDNF selectively pro-
moted motor axon regeneration (Santos et al., 2016). The NGF and
BDNF selective effect on sensory or motor axons has been explained
as the selective expression pattern of their high affinity receptors.
Sensory neurons express the NGF high affinity receptor tropomyosin
receptor kinase A whereas motor neurons express the BDNF
high affinity receptor TrkB (Averill, McMahon, Clary, Reichardt, &
Priestley, 1995; Tovar, Ramirez-Jarquin, Lazo-Gomez, & Tapia, 2014).
Although NGF appears to be necessary and beneficial for sensory
nerve regeneration, it has been shown to participate in the develop-
ment of thermal and mechanical hyperalgesia (Barker, Mantyh,
Arendt-Nielsen, Viktrup, & Tive, 2020; Hu et al., 2017). Therefore, the
use of NGF for peripheral nerve regeneration should also be consid-
ered in pain development following use of NGF to repair the nerve.
Sciatic nerve grafting from Schwann cell specific BDNF knockout mice
into wild type mice showed that axon regeneration into Schwann cell
specific BDNF knockout nerves was markedly reduced (Wilhelm
et al., 2012). In contrast, GDNF expression is upregulated in both
myelinating and nonmyelinating Schwann cells (Naveilhan et al., 1997;
Trupp et al., 1995; Xu et al., 2013). GDNF upregulation is found to be
mediated by the activation of Schwann cell purinergic receptors
followed by protein kinase C and D activation to increase GDNF tran-
scription (Xu et al., 2013). GDNF typically signals via its receptor
GFRα1 complexed with RET-tyrosine kinase, and utilizes MAPK and
phosphatidylinositol 3-kinase/AKT signaling pathways to execute its
biological effects (Takahashi, 2001). Although both sensory and motor
neurons express GFRa1 and Ret (Keast, Forrest, & Osborne, 2010;
Naveilhan et al., 1997), GDNF has a much stronger ability to promote
motor axon regeneration (Hoyng et al., 2014; Tannemaat et al., 2008).
Peripheral nerve regeneration is dramatically impeded in conditional
GDNF knockout mice after crush injury (Dong et al., 2018). However,
how migrating Schwann cells utilizing GDNF as a guidance cue for
regenerating axons crossing the nerve bridge has not been studied in
conditional GDNF knockout mice following transection injury.
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Peripheral nerve injuries are relatively commonplace and primarily
these are transection injuries. Transection injury presents a significant
challenge clinically for effective repair to regain full functional recovery.
Autografts are the current gold standard of peripheral nerve gap repair
but have several limitations such as the lack of grafting material, the
requirement of a second surgery and mismatched nerve structure
(Ray & Mackinnon, 2010). Therefore, biodegradable and biocompatible
nerve guidance conduits have been developed as alternatives to
replace autograft repair (Kehoe et al., 2012). However, despite the
efforts that have been made to improve the structure of the conduit, to
embed neurotrophins and growth factors and to deliver cells within the
conduit, functional recovery has never reached the same level as seen
with autografts for the repair of nerve gaps bigger than 1 cm (Moore
et al., 2009). Furthermore, the peripheral nerve regeneration capacity
declines in older patients as well as in individuals with complications
such as chronic denervation and diabetic neuropathy (Rosenberger
et al., 2020; Jessen & Mirsky, 2019; Painter, 2017), which further
increases the difficulty of finding an effective treatment.
Migrating Schwann cells are the key cell type in the nerve gap guid-
ing regenerating axons into the distal nerve stump. Therefore, the rela-
tionships between Schwann cells and regenerating axons in the nerve
bridge are of particular interest to clinicians and researchers in order to
develop novel therapeutic strategies for effective peripheral nerve gap
repair. Currently, key signals that activate Schwann cell migration or
that Schwann cells use to direct axon regeneration have not been fully
studied in vivo using the nerve transection model. Understanding these
two facets of Schwann cell biology are the most important steps toward
the development of new approaches for repairing such nerve gaps. Use
of the in vivo sciatic nerve transection research model will be an impor-
tant approach to identify these key signals in future studies.
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